Quince Therapeutics, Inc. (QNCX)
NASDAQ·Healthcare·Biotechnology
$29.25
+1.00%
Mkt Cap $5.85M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$69.00
Range $68.00 – $70.00
Implied Upside
+135.9%
Consensus $69.00 vs current $29.25
NASDAQ·Healthcare·Biotechnology
$29.25
+1.00%
Mkt Cap $5.85M
No recent rating data.
Price Target (2 analysts)
$69.00
Range $68.00 – $70.00
+135.9%
Consensus $69.00 vs current $29.25